trending Market Intelligence /marketintelligence/en/news-insights/trending/hi6c5obiut3a_xd8lk_hpq2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

LivaNova to acquire Pittsburgh-based medical device company for $250M

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


LivaNova to acquire Pittsburgh-based medical device company for $250M

LivaNova PLC agreed to acquire Pittsburgh-based privately held medical device company TandemLife for $250 million.

TandemLife is focused on developing advanced cardiopulmonary temporary support solutions. LivaNova said TandemLife's systems are complementary to its offerings in cardiac surgery.

London-based LivaNova will pay a total of $200 million upfront for TandemLife, with up to $50 million in contingent considerations based on regulatory milestones.

The deal is expected to close in the first half of 2018, subject to approvals and other customary closing conditions, and is expected to be modestly accretive in 2018.